The company’s experimental daily pill helped patients lose an average 16.6% of their weight, according to late-stage trial, ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Production is under way and the pill, which helped patients lose an average 16.6% of their weight, is pending regulatory approval in the U.S.

“Currently, less than 2% of individuals with obesity in the U.S. receive obesity medication and Wegovy in a pill may also ...

Whether you take medication for high blood pressure, high cholesterol, depression, or another need, the pharmacy often tucks ...